Astec LifeSciences Limited

NSE ASTEC.NS

Astec LifeSciences Limited Free Cash Flow Yield on February 07, 2025: -7.20%

Astec LifeSciences Limited Free Cash Flow Yield is -7.20% on February 07, 2025, a -192.76% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Astec LifeSciences Limited 52-week high Free Cash Flow Yield is -1.94% on March 19, 2024, which is 73.00% above the current Free Cash Flow Yield.
  • Astec LifeSciences Limited 52-week low Free Cash Flow Yield is -7.20% on February 07, 2025, which is 0.00% below the current Free Cash Flow Yield.
  • Astec LifeSciences Limited average Free Cash Flow Yield for the last 52 weeks is -5.15%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
NSE: ASTEC.NS

Astec LifeSciences Limited

CEO Mr. Arijit Mukherjee
IPO Date Nov. 25, 2009
Location India
Headquarters Godrej One
Employees 606
Sector Materials
Industries
Description

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Similar companies

BALAMINES.NS

Balaji Amines Limited

USD 19.60

-2.29%

DHANUKA.NS

Dhanuka Agritech Limited

USD 16.94

1.22%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 162.23

-1.88%

SUDARSCHEM.NS

Sudarshan Chemical Industries Limited

USD 11.57

-2.19%

BHARATRAS.NS

Bharat Rasayan Limited

USD 114.57

-0.88%

StockViz Staff

February 8, 2025

Any question? Send us an email